TABLE 4.
No. of copies of plasma CMV DNA/ml | No. of time pointsa | No. (%) of time points with ≥50% decline in CMV-specific immune parameterb:
|
||||
---|---|---|---|---|---|---|
Neutraliz- ing Ab | Total Ab | CD4+ T cells | CD8+ T cells | All 4 parametersc | ||
<1,000 | 11 | 2 (18.2) | 4 (36.4) | 9 (81.8) | 8 (72.7) | 2 (18.2) |
>1,000 | 7 | 6 (85.7) | 6 (85.7) | 7 (100) | 7 (100) | 6 (85.7) |
P valued | <0.05 | 0.07 | 0.50 | 0.25 | <0.05 |
Time points at which all four CMV-specific immune parameters were measured.
Time points from 10 of 11 SIV-infected macaques with detectable CMV viremia.
Anti-CMV neutralizing Ab, anti-CMV total Ab, CMV-specific CD4+ T cells and CMV-specific CD8+ T cells.
Fisher's exact probability test.